Actively Recruiting

Phase Not Applicable
Age: 18Years - 100Years
All Genders
NCT05865327

UltrasouNd-guided Percutaneous Intercostal Nerve Cryoneurolysis for Analgesia Following Traumatic Rib Fracture

Led by Sunnybrook Health Sciences Centre · Updated on 2025-09-12

24

Participants Needed

1

Research Sites

110 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Traumatic rib fractures (i.e., broken ribs caused by a physical injury) are common and very painful. They also often lead to serious complications, more time spent in hospital, and can even lead to death. Even after rib fractures have healed, they can lead to long-term pain and a lower quality of life. A technology called cryoneurolysis, which acts to freeze nerves causing pain using a small tool which can turn very cold, is a promising new way to manage rib fracture pain. This study is a test with a small number of people to see if it is feasible to use this technology for patients with rib fractures. If this is successful, we will recruit more people for a larger study to see if cryoneurolysis, along with standard pain control techniques, is better at stopping pain, compared to just the normal techniques alone. Participants in our study will be asked to rate their pain, and record pain medications that they take for 3 months after their pain procedure.

CONDITIONS

Official Title

UltrasouNd-guided Percutaneous Intercostal Nerve Cryoneurolysis for Analgesia Following Traumatic Rib Fracture

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Have 3 to 8 unilateral traumatic rib fractures
  • Suitable candidate for erector spinae plane (ESP) block catheter
  • Admitted to hospital within 48 hours of injury
Not Eligible

You will not qualify if you...

  • Do not consent to participate or unlikely to comply with follow-up
  • Unable to use Patient Controlled Regional Analgesia (due to ventilation, sedation, or moderate to severe brain injury)
  • Chronic pain with opioid use over 30mg oral morphine equivalent daily
  • Substance use disorder
  • Creatinine clearance less than 50
  • Body mass index over 45
  • Significant distracting injuries such as unreduced long bone fractures, unstable pelvic or spine fractures, or requiring trauma laparotomy
  • Contraindications for ESP catheter placement including medical, neurological, or hematologic diseases, infection or trauma at the intervention site, or allergy to amide local anesthetics
  • Contraindications to cryoneurolysis including cryoglobulinemia, paroxysmal cold hemoglobinuria, multiple myeloma, or cold urticaria
  • Unable to return to Trauma Recovery Clinic (in-person or virtual) at 3 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Sunnybrook Health Sciences Centre

Toronto, Ontario, Canada, M4N3M5

Actively Recruiting

Loading map...

Research Team

B

Ben Safa, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here